Natural Alternatives International (NASDAQ:NAII – Get Free Report) and BioHarvest Sciences (NASDAQ:BHST – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.
Earnings & Valuation
This table compares Natural Alternatives International and BioHarvest Sciences”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Natural Alternatives International | $129.86 million | 0.10 | -$13.57 million | ($2.39) | -0.83 |
| BioHarvest Sciences | $34.51 million | 1.03 | -$11.14 million | ($0.52) | -3.48 |
Institutional and Insider Ownership
32.4% of Natural Alternatives International shares are held by institutional investors. 20.8% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Natural Alternatives International has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500.
Profitability
This table compares Natural Alternatives International and BioHarvest Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Natural Alternatives International | -10.13% | -12.21% | -5.30% |
| BioHarvest Sciences | -31.21% | -58.30% | -25.60% |
Analyst Recommendations
This is a breakdown of current ratings and price targets for Natural Alternatives International and BioHarvest Sciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Natural Alternatives International | 1 | 0 | 0 | 0 | 1.00 |
| BioHarvest Sciences | 1 | 0 | 2 | 0 | 2.33 |
BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 259.12%. Given BioHarvest Sciences’ stronger consensus rating and higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than Natural Alternatives International.
About Natural Alternatives International
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.
